Brief: Freeline Granted ILAP Designation In U.K. By MHRA For FLT201, For Treatment Of Gaucher Disease

Freeline Therapeutics Holdings

22/05/2023 13:16

May 22 (Reuters) - Freeline Therapeutics Holdings PLC
 FRLN.O :
    * FREELINE GRANTED ILAP DESIGNATION IN UNITED KINGDOM BY
MHRA FOR
FLT201, AN INVESTIGATIONAL GENE THERAPY FOR THE TREATMENT OF
GAUCHER DISEASE

Source text for Eikon:  ID:nGNX8x1k34 
Further company coverage:  FRLN.O 

 ((reuters.briefs@thomsonreuters.com;))